Related references
Note: Only part of the references are listed.Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17
Sophie Agaugue et al.
BLOOD (2011)
Human leukocyte antigen-G in cancer: Are they clinically relevant?
Wei-Hua Yan
CANCER LETTERS (2011)
Expression of HLA-G in patients with hepatocellular carcinoma
Yan Wang et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2011)
HLA-G as predisposing for metastasis
Ines Zidi et al.
MEDICAL HYPOTHESES (2011)
Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer
Hai-Xiao Chen et al.
HUMAN IMMUNOLOGY (2010)
Down-Regulation of HLA Class I Antigen in Human Papillomavirus Type 16 E7 Expressing HaCaT Cells Correlate With TAP-1 Expression
Wei Li et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Low Expression of Human Histocompatibility Soluble Leukocyte Antigen-G (HLA-G5) in Invasive Cervical Cancer With and Without Metastasis, Associated With Papilloma Virus (HPV)
Marcia C. M. Guimaraes et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2010)
Human Leukocyte Antigen-G (HLA-G) Expression in Cervical Lesions: Association With Cancer Progression, HPV 16/18 Infection, and Host Immune Response
Dan-dan Dong et al.
REPRODUCTIVE SCIENCES (2010)
Increase of human papillomavirus-16 E7-specific T helper type 1 response in peripheral blood of cervical cancer patients after radiotherapy
Felix Giovanni Delgado et al.
IMMUNOLOGY (2009)
Non-classical transcriptional regulation of HLA-G: an update
Philippe Moreau et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Beyond the increasing complexity of the immunomodulatory HLA-G molecule
Edgardo D. Carosella et al.
BLOOD (2008)
Correlation Between IL-10 Gene Expression and HPV Infection in Cervical Cancer: A Mechanism for Immune Response Escape
Victor H. Bermudez-Morales et al.
CANCER INVESTIGATION (2008)
Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells
Frederic Gros et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Classical and non-classical HLA molecules and p16INK4a expression in precursors lesions and invasive cervical cancer
Maria Alice G. Goncalves et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2008)
Loss of heterozygosity at 6p21 underling HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas
Y. Yang et al.
TISSUE ANTIGENS (2008)
Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma
Shang-Mian Yie et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma
B. S. Yoon et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2007)
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination
Teresa Cabrera et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer
Shang-rong Ye et al.
MODERN PATHOLOGY (2007)
Immune selective pressure and HLA class I antigen defects in malignant lesions
Chien-Chung Chang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma
Christine F. W. Vermeulen et al.
GYNECOLOGIC ONCOLOGY (2007)
Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma
Breton F. Barrier et al.
GYNECOLOGIC ONCOLOGY (2006)
Loss of heterozygosity at chromosome 6 as a marker of early genetic alterations in cervical intraepithelial neoplasias and microinvasive carcinomas
N. N. Mazurenko et al.
MOLECULAR BIOLOGY (2006)
Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma
JH Zhou et al.
LIFE SCIENCES (2006)
Frequent HLA class I loss is an early event in cervical carcinogenesis
Christine F. W. Vermeulen et al.
HUMAN IMMUNOLOGY (2005)
Integration of high-risk human papillomavirus DNA correlates with HLA genotype aberration and reduced HLA class I molecule expression in human cervical. carcinoma
BC Sheu et al.
CLINICAL IMMUNOLOGY (2005)
Distribution of HLA class I altered phenotypes in colorectal carcinomas:: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21
I Maleno et al.
IMMUNOGENETICS (2004)
Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix
A Chil et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2003)
HLA-G and IL-10 expression in human cancer - different stories with the same message
M Urosevic et al.
SEMINARS IN CANCER BIOLOGY (2003)
MHC class I antigens, immune surveillance, and tumor immune escape
A Garcia-Lora et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
BLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas
M Urosevic et al.
BLOOD (2002)
Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production
M Urosevic et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer
BC Sheu et al.
JOURNAL OF IMMUNOLOGY (2001)
Cytokines and immune response in the tumor microenvironment
S Mocellin et al.
JOURNAL OF IMMUNOTHERAPY (2001)
A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity
R Marchal-Bras-Goncalves et al.
TRANSPLANTATION PROCEEDINGS (2001)
HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition
B Riteau et al.
INTERNATIONAL IMMUNOLOGY (2001)
Criteria to define HLA haplotype loss in human solid tumors
LM Ramal et al.
TISSUE ANTIGENS (2000)
Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer
LA Koopman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)